Expert Opinion on Drug Delivery

Papers
(The H4-Index of Expert Opinion on Drug Delivery is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer118
Intranasal administration of antiseizure drugs using new formulation trends: one step closer to reach clinical trials56
What is the future potential of microbially degradable systems in oral drug delivery to the colon?55
Artificial Intelligence’s role in colon-targeted drug delivery54
Bringing intranasal drug delivery for malignancies in the brain to market53
Recent advances in the application of clay-containing hydrogels for hemostasis and wound healing52
In vitro modelling of intramuscular injection site events50
Ketamine-polymer based drug delivery system for prolonged analgesia: recent advances, challenges and future prospects44
Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges39
Magnetic hybrid nanovesicles for the precise diagnosis and treatment of central nervous system disorders38
Essential considerations towards development of effective nasal antibiotic formulation: features, strategies, and future directions38
Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology38
Hydrogels for brain repair: application to Parkinson’s disease35
Continuous infusion aerosol delivery of prostacyclins during mechanical ventilation: challenges, limitations, and recent advances34
Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study33
Magnetoliposomes: recent advances in the field of controlled drug delivery32
Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation32
Calcium phosphate coated nanoparticles for drug delivery: where are we now?31
How can nanoemulsions be used for photosensitizer drug delivery?30
The blood–brain barrier as a treatment target for neurodegenerative disorders29
The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids29
All-trans retinoic acid in anticancer therapy: how nanotechnology can enhance its efficacy and resolve its drawbacks29
An opinion on advanced cancer immunotherapy through innovations in PD-1 inhibitor delivery systems29
In vivo dermal delivery of bleomycin with electronic pneumatic injection: drug visualization and quantification with mass spectrometry29
Current advances in cell therapeutics: a biomacromolecules application perspective28
Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies28
Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammat26
Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery26
0.023391962051392